Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact firstname.lastname@example.org.
SOURCE Vascular Flow Technologies
DUNDEE, Scotland, April 30, 2014 /PRNewswire/ --
Forum uniquely brings together leading family offices and their foundations seeking impact investment, grant-giving, and philanthropy opportunities within health and life sciences
Vascular Flow Technologies Ltd, a medical device company focused on the research, development and commercialisation of vascular devices announced today it has been selected to present at the Cavendish Global Health Impact Forum taking place May 5-7 New York, NY. The purpose of the Forum is to help family offices and foundations develop and implement their individual pro-social impact investing, grant-giving, and philanthropy programs within health and the life sciences. To accomplish this mission the Forum showcases presentations and panel discussions by leading scientists, accomplished healthcare delivery professionals, health-policy experts and private-sector companies engaged in developing innovations with the potential for transformational impact on disease prevention, diagnosis and treatment. Michael Moffat, Cavendish co-founder and President explains, "With the help of our expert advisors, we conduct a global search of research institutions and private-sector companies in order to identify organizations that meet the required standard of excellence. The quality and originality of Vascular Flow Technology's research and scientific insights in peripheral arterial/venous disease and arteriovenous access for haemodialysis patients positions them to make a major contribution to the treatment of these diseases/conditions.
"We are honoured to be selected to present at this unique event, and it is further recognition of our innovative approach to treating peripheral vascular conditions afflicting populations around the world today," said Bill Allan, CEO. "We welcome the chance to interact with many of world's leading scientific minds, thought-leaders and generous philanthropic individuals and families who are all dedicated to the common cause of improving the health and lives of people around the world."
Cavendish Global consists of over 150 leading family offices and foundations from around the world with combined assets of over $190 billion who share a passion for pro-social endeavors within health and the life sciences. The Cavendish Global Health Impact Forum provides family offices with a discrete, peer-to-peer knowledge expansion and relationship building environment, combined with the information and educational resources required by foundations actively seeking to accelerate technological innovation and health access through sustainable philanthropy, grant-making and impact investing. The Forum is also an opportunity for family offices to champion and share information on projects and organizations, which they are passionate about with other family offices from around the world. Cavendish Global together with the Global Partnerships Forum and the New York Academy of Sciences organizes the Forum annually in New York.
Notes to Editors
About Vascular Flow Technologies
Vascular Flow Technologies is a dynamic, growing medical devices company operating globally. They are focused on the research, development and commercialisation of vascular devices based on a new understanding of blood flow dynamics - Spiral Laminar Flow™.
Spiral Laminar Flow™ is their technology platform that restores the blood flow pattern through prosthetic grafts to the body's natural state - spiral flow.
Their innovative technology is currently applied to two synthetic grafts: our Spiral Flow™ peripheral bypass graft and our Spiral Flow™ arteriovenous access graft for haemodialysis. Vascular Flow grafts are the ONLY grafts proven to recreate Spiral Laminar Flow™, the body's natural blood flow pattern, improving graft patency and helping to prevent disease progression resulting in better outcomes for the surgeon, care-giver and patient.
Their objective is to help Clinicians improve patient outcomes in Vascular Interventions through the development of Devices that restore normal Spiral Laminar Blood flow.
Vascular Flow's novel technology was developed from Ninewells Hospital (teaching hospital in Dundee, Scotland) by three leading physicians.
Further information is available on the Company's website, http://www.vascular-flow.com.
About Cavendish Global
Cavendish Global provides family offices and their foundations with a discrete, peer-to-peer knowledge expansion and relationship building environment, combined with the innovative resources required to help develop and implement their individual pro-social impact investment, grant making and philanthropy programs within health and the life sciences. Cavendish Global provides family offices with a number of innovative resources, which includes Cavendish Impact Forums. A unique gathering of leading family offices, Cavendish Impact Forums take place three times each year; in the United States (taking place in New York at the United Nations Headquarters May 5th to 7th 2014), Europe (UK, November 2014, in association with SV Life Sciences, hosted by Oxford University ) and a third event held at a Cavendish Host Partner City which moves to a different global location each year (Dubai, UAE January 2015).
For more information: http://cavendishglobal.com
Bill Allan: +44(0)7920-143-030
Kate Full: +44(0)1382-598-532
Caroline Thoms: +44(0)1382-598-532
©2012 PR Newswire. All Rights Reserved.